Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy
2005
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants
2005 Standout
The Epidemiology of Major Depressive Disorder
2003 Standout
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
2006 Standout
Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder
2004 Standout
Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics
2003
Antiepileptic drugs: indications other than epilepsy
2004
Challenges to evidence-based medicine:
2004
Glutamate receptor ion channels
2005 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Are impulse-control disorders related to bipolar disorder?
1996
Long-Term Associations of Childhood Suicide Ideation
2007
Cognitive and Behavioral Effects of Antiepileptic Drugs
1995
Emotion-regulation strategies across psychopathology: A meta-analytic review
2009 Standout
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2001 Standout
The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective
2013
Effectiveness-implementation Hybrid Designs
2012 Standout
Lithium Treatment of Acute Mania in Adolescents: A Placebo-Controlled Discontinuation Study
2004
Pharmacology of Antidepressants
1997
Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: What depression has in common with impulsive aggression.
2008
Twelve-Month Use of Mental Health Services in the United States
2005 Standout
Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders
2003
Antipsychotic agents in the treatment of bipolar mania
2009
Divalproex in posttraumatic stress disorder: An open‐label clinical trial
1999
A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder
2000
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The Continuing Unethical Use of Placebo Controls
1994
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
What Makes Clinical Research Ethical?
2000 Standout
A Double-Blind, Randomized, Placebo-Controlled Study of Quetiapine as Adjunctive Treatment for Adolescent Mania
2002
Risk factors for suicide among 34,671 patients with psychotic and non-psychotic severe depression
2013
Medication Compliance and Persistence: Terminology and Definitions
2007 Standout
What Is a “Mood Stabilizer”? An Evidence-Based Response
2004
Clinician-administered PTSD scale: A review of the first ten years of research
2001 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Suicide risk in mood disorders
2006
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
The place of anticonvulsant therapy in bipolar illness
1996
Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy
1999
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
2009
Prevention of Venous Thromboembolism
2004 Standout
Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness
1999
Neurobiology of Depression
2002 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder
2003
Major Depressive Disorder
2008 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Consensus Statement on Management of Intersex Disorders
2006 Standout
Prevention of Venous Thromboembolism
2008 Standout
Inhibition of [3H]α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid [AMPA] binding by the anticonvulsant valproate in clinically relevant concentrations: an autoradiographic investigation in human hippocampus
1998
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
2008 Standout
Lithium stimulates gene expression through the AP-1 transcription factor pathway
1998
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
1997 Standout
GABA and mood disorders: a brief review and hypothesis
1995
A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients
1999 Standout
The interpersonal theory of suicide.
2010 Standout
Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features
2001
Trends in the Treatment of Bipolar Disorder by Outpatient Psychiatrists
2002
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
2003
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
2001 Standout
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Results of a naturalistic study of treatment options: Switching atypical antipsychotic drugs or augmenting with valproate
2004
Adipose Tissue as an Endocrine Organ
2004 Standout
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
2000
Current psychiatric morbidity, aggression/impulsivity, and personality dimensions in child and adolescent suicide: A case-control study
2007
Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP
1997 Standout
The Epidemiology of Depression Across Cultures
2013 Standout
Differential Display PCR Reveals Novel Targets for the Mood-Stabilizing Drug Valproate Including the Molecular Chaperone GRP78
1999
Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?
2003
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
2014
Gabapentin and Lamotrigine: Novel Treatments for Mood and Anxiety Disorders
1997
Corpus callosum abnormalities in pediatric bipolar disorder
2009
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
2004
The Glutamate Receptor Ion Channels
1999 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
2011 Standout
GSK-3: tricks of the trade for a multi-tasking kinase
2003 Standout
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
2000
Annual Research Review: Enduring neurobiological effects of childhood abuse and neglect
2016 Standout
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
2006 Standout
Principles of effectiveness trials and their implementation in VA Cooperative Study #430: ‘Reducing the Efficacy-Effectiveness Gap in Bipolar Disorder’
2001
Delirium in the Elderly
1988
Works of C.L. Bowden being referenced
Trait impulsivity in patients with mood disorders
2006
Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients
2006
Central visfatin causes orexigenic effects in chicks
2007
Relation of serum valproate concentration to response in mania
1996
P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial
2003
Toxic psychosis with cimetidine
1979
Olanzapine in the treatment of bipolar depression
2002
Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression
1990
Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE)
2003
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
1994